Corpechot C - Search Results

1

Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.

Lammers WJ, Hirschfield GM, Corpechot C, Nevens F, Lindor KD, Janssen HL, Floreani A, Ponsioen CY, Mayo MJ, Invernizzi P, Battezzati PM, Parés A, Burroughs AK, Mason AL, Kowdley KV, Kumagi T, Harms MH, Trivedi PJ, Poupon R, Cheung A, Lleo A, Caballeria L, Hansen BE, van Buuren HR; Global PBC Study Group. Lammers WJ, et al. Among authors: corpechot c. Gastroenterology. 2015 Dec;149(7):1804-1812.e4. doi: 10.1053/j.gastro.2015.07.061. Epub 2015 Aug 7. Gastroenterology. 2015. PMID: 26261009

2

The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.

Corpechot C, Carrat F, Bonnand AM, Poupon RE, Poupon R. Corpechot C, et al. Hepatology. 2000 Dec;32(6):1196-9. doi: 10.1053/jhep.2000.20240. Hepatology. 2000. PMID: 11093724 Clinical Trial.

3

Fetal microchimerism in primary biliary cirrhosis.

Corpechot C, Barbu V, Chazouillères O, Poupon R. Corpechot C, et al. J Hepatol. 2000 Nov;33(5):696-700. doi: 10.1016/s0168-8278(00)80298-6. J Hepatol. 2000. PMID: 11097475

4

Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?

Corpechot C, Benlian P, Barbu V, Chazouillères O, Poupon RE, Poupon R. Corpechot C, et al. J Hepatol. 2001 Sep;35(3):324-8. doi: 10.1016/s0168-8278(01)00137-4. J Hepatol. 2001. PMID: 11592592

5

Promoter polymorphism of the CD14 endotoxin receptor gene and primary biliary cirrhosis.

Corpechot C, Poupon R. Corpechot C, et al. Hepatology. 2002 Jan;35(1):242-3. doi: 10.1053/jhep.2002.30279. Hepatology. 2002. PMID: 11786986 No abstract available.

6

Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.

Corpechot C, Barbu V, Wendum D, Chignard N, Housset C, Poupon R, Rosmorduc O. Corpechot C, et al. Am J Pathol. 2002 Feb;160(2):613-20. doi: 10.1016/S0002-9440(10)64881-X. Am J Pathol. 2002. PMID: 11839582 Free PMC article.

7

Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients.

Corpechot C, Carrat F, Poupon R, Poupon RE. Corpechot C, et al. Gastroenterology. 2002 Mar;122(3):652-8. doi: 10.1053/gast.2002.31880. Gastroenterology. 2002. PMID: 11874998

8

Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis.

Corpechot C, Barbu V, Wendum D, Kinnman N, Rey C, Poupon R, Housset C, Rosmorduc O. Corpechot C, et al. Hepatology. 2002 May;35(5):1010-21. doi: 10.1053/jhep.2002.32524. Hepatology. 2002. PMID: 11981751

9

Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.

Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chrétien Y, Poupon RE, Poupon R. Corpechot C, et al. Liver Int. 2004 Jun;24(3):187-93. doi: 10.1111/j.1478-3231.2004.0918.x. Liver Int. 2004. PMID: 15189267

10

The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis.

Corpechot C, Carrat F, Bahr A, Chrétien Y, Poupon RE, Poupon R. Corpechot C, et al. Gastroenterology. 2005 Feb;128(2):297-303. doi: 10.1053/j.gastro.2004.11.009. Gastroenterology. 2005. PMID: 15685541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters